Yu Yang

Yu Yang

Auto-generated profile, based on publicly available information

Yu Yang

National Institute of Health Data Science, Peking University, Beijing, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ZLZhike Liu
Zhike Liu
LZLiang Zhang
Liang Zhang
YYYu Yang
Yu Yang
RMRuogu Meng
Ruogu Meng
TFTing Fang
Ting Fang
SZSiyan Zhan
Siyan Zhan
Background: Comprehensive safety data for vaccines from post-licensure surveillance, especially active surveillance, could guide administrations and individuals to make reasonable decisions on vaccination. Therefore, we designed a pilot study to assess the capability of a regional health care information platform to actively monitor the safety of a newly licensed vaccine. Objective: This study aimed to conduct active surveillance of human papillomavirus (HPV) vaccine safety based on this information platform. Methods: In 2017, one of China’s most mature information platforms with superior data linkage was selected. A structured questionnaire and open-ended interview guidelines were developed to investigate the feasibility of active surveillance following HPV vaccination using the regional health care information platform in Ningbo. The questionnaire was sent to participants via email, and a face-to-face interview was conducted to confirm details or resolve discrepancies. Results: Five databases that could be considered essential to active surveillance of vaccine safety were integrated into the platform starting in 2015. Except for residents' health records, which had a coverage rate of 87%, the data sources covered more than 95% of the records that were documented in Ningbo. All the data could be inherently linked using the national identity card. There were 19,328 women who received the HPV vaccine, and 37,988 doses were administered in 2017 and 2018. Women aged 30-40 years accounted for the largest proportion. Quadrivalent vaccination accounted for 73.1% of total vaccination, a much higher proportion than that of bivalent vaccination. Of the first doses, 60 (60/19,328, 0.31%) occurred outside Ningbo. There were no missing data for vaccination-relevant variables, such as identity card, vaccine name, vaccination doses, vaccination date, and manufacturer. ICD-10 coding could be used to identify 9,180 cases using a predefined list of the outcomes of interest, and 1.88% of these cases were missing the identity card. During the 90 days following HPV vaccination, 4 incident cases were found through the linked vaccination history and electronic medical records. The combined incident rate of rheumatoid arthritis, optic neuritis, and Henoch-Schonlein purpura was 8.84/100,000 doses of bivalent HPV, and the incidence rate of rheumatoid arthritis was 3.75/100,000 doses of quadrivalent HPV. Conclusions: This study presents an available approach to initiate an active surveillance system for adverse events following HPV vaccination, based on a regional health care information platform in China. An extended observation period or the inclusion of additional functional sites is warranted to conduct future hypothesis-generating and hypothesis-confirming studies for vaccine safety concerns.

1 January 2021 in Health Data Science
Verified
Journal Article
Open access
PDF file
ZLZhike Liu
Zhike Liu
RMRuogu Meng
Ruogu Meng
YYYu Yang
Yu Yang
KLKeli Li
Keli Li
ZYZundong Yin
Zundong Yin
SZSiyan Zhan
Siyan Zhan
Importance . The great success in vaccine-preventable diseases has been accompanied by vaccine safety concerns. This has caused vaccine hesitancy to be the top 10 in threats to global health. The comprehensive understanding of adverse events following immunization should be entirely based on clinical trials and postapproval surveillance. It has increasingly been recognized worldwide that the active surveillance of vaccine safety should be an essential part of immunization programs due to its complementary advantages to passive surveillance and clinical trials. Highlights . In the present study, the framework of vaccine safety surveillance was summarized to illustrate the importance of active surveillance and address vaccine hesitancy or safety concerns. Then, the global progress of active surveillance systems was reviewed, mainly focusing on population-based or hospital-based active surveillance. With these successful paradigms, the practical and reliable ways to create robust and similar systems in China were discussed and presented from the perspective of available databases, methodology challenges, policy supports, and ethical considerations. Conclusion . In the inevitable trend of the global vaccine safety ecosystem, the establishment of an active surveillance system for vaccine safety in China is urgent and feasible. This process can be accelerated with the consensus and cooperation of regulatory departments, research institutions, and data owners.

11 July 2013 in Frontiers of Medicine
Verified
Journal Article
Closed access
PDF file
XLXiangwei Li
Xiangwei Li
YYYu Yang
Yu Yang
JLJian-Min Liu
Jian-Min Liu
FZFeng Zhou
Feng Zhou
WCWei Cui
Wei Cui
LGLei Gao
Lei Gao

14 August 2017 in Molecular and Clinical Oncology
Verified
Journal Article
Open access
PDF file
CLCanbin Lin
Canbin Lin
LJLu Jin
Lu Jin
YYYu Yang
Yu Yang
YDYu Ding
Yu Ding
XWXionghui Wu
Xionghui Wu
YLYongqing Lai
Yongqing Lai
In the general population, tuberous sclerosis‑associated renal angiomyolipoma (RAML) is a rare benign hamartoma with potentially life‑threatening complications and a poor prognosis. The two patients reported in the present study, who were diagnosed with bilateral RAML and spontaneous rupture of the RAML with tuberous sclerosis, presented with flank pain, abdominal pain, hemorrhage, hematuria and multiple lesions. The two cases are representative examples of the disease, and highlight the importance of determining the risk of acute hemorrhage in the early stages, and the significance of timely and proper treatment.

1 July 2020 in JMIR Medical Informatics
Verified
Journal Article
Open access
LZLin Zhuo
Lin Zhuo
YCYinchu Cheng
Yinchu Cheng
SLShaoqin Liu
Shaoqin Liu
YYYu Yang
Yu Yang
STShuang Tang
Shuang Tang
SZSiyan Zhan
Siyan Zhan
Background: The inappropriate use of prescription medication has recently garnered worldwide attention, but most national policies do not effectively provide for early detection or timely intervention. Objective: This study aimed to develop and assess the validity of a model that can detect the inappropriate use of prescription medication. This effort combines a multiview and topic matching method. The study also assessed the validity of this approach. Methods: A multiview extension of the latent Dirichlet allocation algorithm for topic modeling was chosen to generate diagnosis-medication topics, with data obtained from the Chinese Monitoring Network for Rational Use of Drugs (CMNRUD) database. Topic mapping allowed for calculating the degree to which diagnoses and medications were similarly distributed and, by setting a threshold, for identifying prescription misuse. The Beijing Regional Prescription Review Database (BRPRD) database was used as the gold standard to assess the model's validity. We also conducted a sensitivity analysis using random samples of validated prescriptions and evaluated the model's performance. Results: A total of 44 million prescriptions were used to generate topics using the diagnoses and medications from the CMNRUD database. A random sample (15,000 prescriptions) from the BRPRD was used for validation, and it was found that the model had a sensitivity of 81.8%, specificity of 47.4%, positive-predictive value of 14.5%, and negative-predictive value of 96.0%. The model showed superior stability under different sampling proportions. Conclusions: A method that combines multiview topic modeling and topic matching can detect the inappropriate use of prescription medication. This model, which has mediocre specificity and moderate sensitivity, can be used as a primary screening tool and will likely complement and improve the process of manually reviewing prescriptions.

24 August 2024
Verified
Conference Paper
Open access
SHShenda Hong
Shenda Hong
DYDaoxin Yin
Daoxin Yin
GTGongzheng Tang
Gongzheng Tang
TFTianfan Fu
Tianfan Fu
LMLiantao Ma
Liantao Ma
LZLuxia Zhang
Luxia Zhang
KDD AIDSH 2024 aims to foster discussions and developments that push the boundaries of Artificial Intelligence (AI) and Data Science (DS) in healthcare, enhance diagnostic accuracy and promote human-centric approaches to healthcare, thus stimulating future interdisciplinary collaborations. This year's symposium will focus on expanding the application of AI/DS in healthcare/medicine and bridging existing gaps. The workshop invites submissions of full papers as well as work-in-progress on the application of AI/DS in healthcare. The workshop will feature three invited talks from eminent speakers, spanning academia, industry, and clinical researchers. In addition, selected papers will be invited to publish in Health Data Science, a Science Partner Journal. This summary provides a brief description of the half-day workshop to be held on August 26th, 2024. The webpage for the workshop can be found at https://aimel.ai/kdd2024aidsh.